Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production

Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production

US Patent 11484529 · Granted Nov 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for drying an impregnated blank and associated manufacturing method, syst2025
Prevention of the risks associated with drug-induced QT interval prolongation by2023
Prevention and treatment of benign prostatic hyperplasia using a selective inhib2022
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2022
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2022
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2022
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2020
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2020
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2020
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2019
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2019
Compounds for the treatment of diseases linked to mitochondrial reactive oxygen 2019